These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23169538)

  • 1. A very low carbohydrate ketogenic diet prevents the progression of hepatic steatosis caused by hyperglycemia in a juvenile obese mouse model.
    Okuda T; Morita N
    Nutr Diabetes; 2012 Nov; 2(11):e50. PubMed ID: 23169538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independently of weight loss.
    Badman MK; Kennedy AR; Adams AC; Pissios P; Maratos-Flier E
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1197-204. PubMed ID: 19738035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of O-GlcNAc-modified proteins in a mouse model whose glycemic status is controlled by a low carbohydrate ketogenic diet.
    Okuda T; Fukui A; Morita N
    Glycoconj J; 2013 Nov; 30(8):781-9. PubMed ID: 23793825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis.
    Massart J; Robin MA; Noury F; Fautrel A; Lettéron P; Bado A; Eliat PA; Fromenty B
    Br J Pharmacol; 2012 Mar; 165(5):1361-74. PubMed ID: 21740407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice.
    Xu J; Kulkarni SR; Donepudi AC; More VR; Slitt AL
    Diabetes; 2012 Dec; 61(12):3208-18. PubMed ID: 22936178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency.
    Begriche K; Massart J; Abbey-Toby A; Igoudjil A; Lettéron P; Fromenty B
    Obesity (Silver Spring); 2008 Sep; 16(9):2053-67. PubMed ID: 19186330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
    Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
    J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Emulsion Added to a Liquid High-Carbohydrate Diet and Voluntary Running Exercise Reduce Lipogenesis and Ameliorate Early-Stage Hepatic Steatosis in Mice.
    Huang KH; Hao L; Smith PB; Rogers CJ; Patterson AD; Ross AC
    J Nutr; 2017 May; 147(5):746-753. PubMed ID: 28298542
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term ketogenic diet contributes to glycemic control but promotes lipid accumulation and hepatic steatosis in type 2 diabetic mice.
    Zhang X; Qin J; Zhao Y; Shi J; Lan R; Gan Y; Ren H; Zhu B; Qian M; Du B
    Nutr Res; 2016 Apr; 36(4):349-358. PubMed ID: 27001280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice.
    Ohyama T; Sato K; Yamazaki Y; Hashizume H; Horiguchi N; Kakizaki S; Mori M; Kusano M; Yamada M
    World J Gastroenterol; 2014 Nov; 20(43):16227-35. PubMed ID: 25473177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive changes in amino acid metabolism permit normal longevity in mice consuming a low-carbohydrate ketogenic diet.
    Douris N; Melman T; Pecherer JM; Pissios P; Flier JS; Cantley LC; Locasale JW; Maratos-Flier E
    Biochim Biophys Acta; 2015 Oct; 1852(10 Pt A):2056-65. PubMed ID: 26170063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
    Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
    Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl-CoA carboxylase 2-/- mutant mice are protected against fatty liver under high-fat, high-carbohydrate dietary and de novo lipogenic conditions.
    Abu-Elheiga L; Wu H; Gu Z; Bressler R; Wakil SJ
    J Biol Chem; 2012 Apr; 287(15):12578-88. PubMed ID: 22362781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sitagliptin can inhibit the development of hepatic steatosis in high-fructose diet-fed ob/ob mice.
    Sujishi T; Fukunishi S; Ii M; Nakamura K; Yokohama K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
    J Clin Biochem Nutr; 2015 Nov; 57(3):244-53. PubMed ID: 26566312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maresin 1 mitigates liver steatosis in ob/ob and diet-induced obese mice.
    Laiglesia LM; Lorente-Cebrián S; Martínez-Fernández L; Sáinz N; Prieto-Hontoria PL; Burrell MA; Rodríguez-Ortigosa CM; Martínez JA; Moreno-Aliaga MJ
    Int J Obes (Lond); 2018 Mar; 42(3):572-579. PubMed ID: 28895586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy.
    Kristiansen MN; Veidal SS; Rigbolt KT; Tølbøl KS; Roth JD; Jelsing J; Vrang N; Feigh M
    World J Hepatol; 2016 Jun; 8(16):673-84. PubMed ID: 27326314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.